Farrerol alleviates cognitive impairments in chronic cerebral hypoperfusion via suppressing NLRP3 inflammasome-mediated pyroptosis
International Immunopharmacology · 2025-04 · 153 · 114442
DOI: 10.1016/j.intimp.2025.114442 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-04. Verfasst von Jie Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai …. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Cognitive Dysfunction, Inflammasomes, Neuroprotective Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Science and Technology Innovation Plan Of Shanghai Science and Technology Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Chronic cerebral hypoperfusion (CCH) serves as a critical pathological mechanism that contributes to the development of vascular dementia (VaD). NLRP3 inflammasome activation is a pivotal factor in promoting cognitive decline in CCH. Farrerol, a dihydroflavonoid derived from Rhododendron and other Ericaceae species, possesses anti-inflammatory, antioxidant, and neuroprotective properties. However, its role in regulating pyroptosis triggered by the NLRP3 inflammasome in CCH remains unclear. METHODS: A permanent CCH rat model was generated by occluding the bilateral common carotid arteries (BCCAO), and cellular models of sustained hypoxia were used to mimic CCH in vitro. Eight weeks post-surgery, rats received farrerol treatment. Behavioral tests were conducted after four weeks of treatment. Brain tissues were analyzed via histological staining, immunofluorescence, qRT-PCR, ELISA, and Western blot. The anti-pyroptosis effects and mechanisms of farrerol were also tested in BV2 cells and primary microglia subjected to hypoglycemia and hypoxia conditions. RESULTS: Farrerol markedly alleviated cognitive impairments and neural damage caused by CCH. In CCH rats, farrerol suppressed the activation of the NLRP3 inflammasome, decreased the levels of IL-1β and IL-18, and reduced pyroptosis. The in vitro experiments also demonstrated that farrerol could reduce chronic hypoxia-induced pyroptosis by inhibiting the NLRP3 inflammasome pathway. The cellular study further showed that the beneficial effects of farrerol in CCH are via modulating the MAPK-NF-κB pathway. CONCLUSION: Farrerol mitigates CCH-induced cognitive dysfunction by inhibiting NLRP3 inflammasome-associated pyroptosis via modulating the MAPK-NF-κB signaling cascade. These findings underscore the potential of farrerol as a therapeutic candidate for CCH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai 200233, China; Shanghai Neurological Rare Disease Biobank and Precisio…
- Department of Neurology, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai 200233, China; Department of Neurology, Shanghai Tenth People's Hospit…
Förderung
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Zhang, Y., Zhang, Y., Lu, K., Zhang, X., Wang, X., & Fu, J. (2025). Farrerol alleviates cognitive impairments in chronic cerebral hypoperfusion via suppressing NLRP3 inflammasome-mediated pyroptosis. International Immunopharmacology, 153, 114442. https://doi.org/10.1016/j.intimp.2025.114442
Vancouver
Zhang J, Zhang Y, Zhang Y, Lu K, Zhang X, Wang X, et al. Farrerol alleviates cognitive impairments in chronic cerebral hypoperfusion via suppressing NLRP3 inflammasome-mediated pyroptosis. International Immunopharmacology. 2025;153:114442. doi:10.1016/j.intimp.2025.114442
BibTeX
@article{Zhang2025,
author = {Zhang, Jie and Zhang, Yaxuan and Zhang, Yueqi and Lu, Kaili and Zhang, Xiaojie and Wang, Xiuzhe and Fu, Jianliang},
title = {Farrerol alleviates cognitive impairments in chronic cerebral hypoperfusion via suppressing NLRP3 inflammasome-mediated pyroptosis},
journal = {International Immunopharmacology},
year = {2025},
volume = {153},
pages = {114442},
doi = {10.1016/j.intimp.2025.114442}
}
EUVIMED